SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Positive topline weight-loss maintenance data for Viking Therapeutics' obesity candidate VK2735 is driving the surge in attention, with retail sentiment turning extremely bullish as bulls tout the results as best-in-class and argue the program is now de-risked. The stock's comparatively muted reaction has split the community between longs citing heavy short interest, squeeze potential, and renewed buyout or partnership speculation, and traders treating the move as a sell-the-news event that fell short of some analyst expectations.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending on heavy retail speculation after founder Patrick Soon-Shiong teased a potential push into blockchain-based tokenized stock trading at Nant, with many traders framing potential IBRX tokenization as a way to eliminate naked short selling and pressure the heavily shorted stock. Skeptics in the community dismiss the tease as unconfirmed hype and want therapeutic news instead, while chatter about Soon-Shiong meeting Turkey's president and a January PDUFA date is fueling additional speculation about possible Anktiva catalysts.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with mobility drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, and taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting carriers with shippers on its platform, and gives carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

UBER is trending as traders question why the stock keeps selling off at the open and staying red despite a stream of positive developments, most prominently CEO Dara Khosrowshahi's $10 million open-market share purchase and a roughly $5.3 million buy by the COO. The community is split between reading the insider buying, along with Bill Ackman's disclosed bullish stake, as accumulation at a bottom, and attributing the weakness to autonomous-vehicle competition fears around Tesla and Waymo robotaxis, suspected short-selling pressure or manipulation, and some citing uncertainty over the Delivery Hero acquisition financing.

Royal Caribbean Group is a cruise company, which engages in the ownership and operation of the following global cruise brands: Royal Caribbean International, Celebrity Cruises, and Silversea Cruises. The firm also holds interest in TUI Cruises GmbH, which operates the German brands TUI Cruises and Hapag-Lloyd Cruises. The company was founded by Arne Wilhelmsen in 1968 and is headquartered in Miami, FL.

Royal Caribbean Group

Discussion is fragmented rather than centered on a single catalyst, with the most common themes being oil price volatilityfuel costs, Royal Caribbean's fuel hedging versus unhedged peers CCL and NCLH, and Iran/Strait of Hormuz headlinesand a sharp debate over short-selling, which traders variously call manipulation or an easy short. Smaller threads criticize the company's resort acquisition, cite travel fears from a hantavirus outbreak on a cruise ship, and react to a beat-and-raise earnings report.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending amid a sustained run-up that traders are largely tying to CEO Ryan Cohen's continued open-market share purchases, including a roughly $26 million addition to his stake, which has fueled short-squeeze speculation and debate over the company's warrants. Community reaction is split: some view Cohen's buying as a signal of conviction, others claim the stock is being suppressed by market makers and short sellers, and a few question how much of the rally can really be attributed to insider buying.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is drawing attention around its AI evaluation and red-teaming push, with traders pointing to the Innodata Muse announcement and the addition of former NSA Director Admiral Michael Rogers to the board as an AI-security signal. The community is split on what drove the rally, with some crediting the news and a broader AI-safety theme while others argue the move is a technical breakout amplified by a short squeeze rather than news-driven.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending amid a steep, sustained share decline following its removal from the S&P 500, with traders split on whether index-related selling drove the drop or was largely priced in as growth slows. Heavy short interest is fueling speculation of a potential short-covering rally, while criticism of managementover executive share sales, option repricing, and competition from Amazon, Google, and Metadrives much of the bearish commentary.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is drawing heavy attention after a sharp rally to multi-year highs on a large quarterly revenue beat (roughly $32M versus ~$12M expected), which traders credit to the early commercial ramp of Yartemlea (narsoplimab) against a still-small ~$1.5B market cap. The heavily bullish discussion centers on whether elevated short interest could fuel a squeeze if shares break $20, with competing debate over EU re-examination hopes, possible buyout interest, and caution from some that the crowd may be getting ahead of the fundamentals.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Chatter centers on a sharp rally to fresh 52-week highs, up more than 20% in four sessions, with the most-cited catalyst being an analyst upgrade to Overweight and a raised price target based on a physician survey highlighting lifileucel durability and upcoming lung-cancer (NSCLC) catalysts. The community is also debating short-covering and options-expiry positioning around a heavily traded strike, while awaiting an expected upward revision to full-year revenue guidance.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending on a sharp intraday sell-off and reversal from its recent highs, with many traders attributing the weakness to Meta's Muse AI agent launch fueling competitive concerns in consumer AI, alongside broader Magnificent Seven softness. The community is split between aggressive dip-buying backed by heavy bullish call flow and bears who argue the pullback reflects an overextended stock.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Weighs Impact On DYN Stock Post Novartis’ Phase 3 Failure — RBC Says These Key Differences Could Lead To Better Outcomes

Equity

RBC Capital highlighted differences in how Novartis’ and Dyne’s drugs target transferrin protein, their payloads, and their clinical trial designs.

NVS Stock Clocks Worst Day In Over 20 Years After Second Trial Failure In A Week — DYN, SRPT Slip In Sympathy

The company said on Tuesday that its experimental drug del-desiran failed in a late-stage trial. 

Novartis Myotonic Dystrophy Trial Flop Sends Dyne Therapeutics Shares Tumbling

Dyne Therapeutics stock sinks on Novartis' failed Phase 3 myotonic dystrophy study, even as Dyne prepares new trial data presentations.read more...

SRPT Stock Slides 10% in a Week: Is Dyne Therapeutics a Threat?

Sarepta falls nearly 10% in a week after Dyne Therapeutics wins FDA priority review for a rival DMD therapy that could challenge Exondys 51 if approved.

Dyne Therapeutics Stock Tumbles After Hours: Here's Why

Dyne Therapeutics stock fell after hours after pricing an upsized $375M public offering of common stock.read more...

Why DYN Shares Are Down 10% After-Hours? Day After An FDA Win, Another Announcement Rocks Stock

Dyne Therapeutics announced plans to raise $300 million through a public stock offering on Tuesday.


SRPT Stock Drops 4% As Citi Flags Potentially Stronger Rival In Duchenne Space

Citi reiterated a ‘Sell’ rating on SRPT, citing the expected rise in competition within the Duchenne muscular dystrophy (DMD) exon-skipping market.


DYN Stock Rises 19.2% in 3 Months: What's Driving the Rally?

Dyne gains momentum as FDA priority review for its lead DMD therapy and progress in its DM1 program strengthen confidence in its pipeline.

Dyne Therapeutics vs. Recursion Pharmaceuticals: Which Development Stage Pharma Stock Is a Better Buy in 2026?

Dyne Therapeutics vs. Recursion Pharmaceuticals: Which Development Stage Pharma Stock Is a Better Buy in 2026...

Dyne Therapeutics vs. Vertex Pharmaceuticals: Which Drug Innovator Stock Is a Better Buy in 2026?

Key PointsDyne Therapeutics focuses on high-potential therapies for rare neuromuscular diseases using its proprietary FORCE platform...

Dyne Therapeutics, Inc. is a clinical-stage company, which engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystrophy. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.

Dyne Therapeutics Inc

Neutral Sentiment

Job displacement

Market bubble / overvaluation

Loss of human oversight / control

Killer robots 🤖

As AI spending accelerates across hyperscalers and valuations climb to historic highs, investors and workers alike are increasingly debating the risks the technology poses - from job displacement to fears about losing human oversight over increasingly autonomous systems. What do you think is the biggest threat AI poses? Vote and explain your reasoning in the comments.

Current Price	$17.24
Prev Close	$17.12
Open	$17.37
Dividend Yield	0.00%
50-Day Moving Average	$23.85
Beta	1.88
Avg. Volume	1.78M
PE Ratio	-5.14

52-Week High	$27.31
52-Week Low	$11.92
Market Capitalization	$3.2B
EPS (Annual)	-$3.47
Price to Book	4.04
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

DYN Fundamentals